Jeremy Docken (@JeremyGDocken) header
Jeremy Docken (@JeremyGDocken) profile picture

Discussing issues facing the healthcare system and joys and challenges of running a healthcare technology company. Plus other things that I find interesting.

Chicago, IL
Joined March 2020
Photo by Jeremy Docken (@JeremyGDocken)
As I have stated previously, @GoodRx is a PBM scam, another form of spread pricing. Patients benefit from paying cash for some of the most often prescribed generic medications. There are far better options for patients to pay cash e.g., Costco drugchannels.net/2022/11/beh…
1
4
5
Jeremy Docken retweeted
I bet there are some grumpy faces up in Dublin, Ohio this evening after reading this one. Ouch.
Warren Buffett once said that the best business to be in is a royalty on the growth of others. Cardinal Health has seen declining profitability even though that's basically what a drug distributor does-- take a royalty on the growth of the pharma industry. wsj.com/articles/failing-in-…
1
2
3
Insurers and PBMs are Undermining Employee Health Benefits Employers have the power and they need to ensure that their employee drug benefits are protected from PBM/insurer profit-seeking practices @GHLForg @ppi @PioneerBoston healthcarebusinesstoday.com/… via @HCBizToday
1
9
3
14
Jeremy Docken retweeted
A timely reminder that #insulin #drug prices are not what they seem: "Understanding Insulin Prices" Do politicians understand that out-of-pocket costs, not list prices, are patients’ biggest challenge? @PioneerBoston @InsideSourcesDC #GrossToNetBubble drugch.nl/3xb8rPW
1
5
2
11
Drug Channels News Roundup, January 2022 In this issue: - An update on the #GrossToNetBubble for #insulin - OptumRx trolls us - Patients vs. high-deductible health plans - #340B's unstoppable growth Plus: Fun with the CDC Read it all here ==> drugch.nl/3KHb8NR
Dear Lawmakers @POTUS @RonWyden @SpeakerPelosi Hundreds of us biotech investors, innovators, patient advocates, & NIH academics representing >40k US jobs, >600 drugs in trials, & >$200B invested propose solutions to affordability that preserve R&D. 1/ nopatientleftbehind.docsend.…
12
134
28
281
The cost of drugs has long been a hot-button topic, but how might the landscape be changing for 2021? The Current State of Drug Pricing and Forecasts for the Future explores what drug makers need to know as the Biden administration tackles #drugpricing ➡️pharmexec.com/view/the-curre…
3
3
Jeremy Docken retweeted
R.I.P., #rebate rule @HHSGov delays world w/o rebates until at least 2023, due to @pcmanet lawsuit: drugch.nl/3oBokHV Good news for #PBMs & #GrossToNetBubble ; Bad news for patients taking deeply-discounted #drugs 😔 My still-relevant 2019 $0.02: drugch.nl/2WSR83k
7
12
2
26
Questions: What happens to patients whose medication is no longer covered by the PBM? Do insurers who now supposedly own these PBMs care about the total cost of care due to poor outcomes? Answers: WHO CARES & NO since rebate contracting driving this behavior is far more lucrative
PCMA will always protect the rebate contracting gravy train, as it is the most lucrative part of the RX benefit management & AARP opposing the rebate rule is because AARP is a PBM & not a patient group as advertised read👇 hsj.gr/medicine/reforming-re… fiercehealthcare.com/payer/p…
3
8
2
10
Jeremy Docken retweeted
Curious about others’ reactions to my belief that @ONC_HealthIT's info blocking rule is a really, really big deal. As in, perhaps more so than anything in the previous or next 5 years. forbes.com/sites/sethjoseph/…
2
2
3
Jeremy Docken retweeted
Worth reading: Pretty balanced article on #340B contract pharmacy issues from @JohnRussell99 @IBJnews drugch.nl/3iqnM4j
2
5
Whoa. New @CMSGov notice states that any #drugs imported under new final rule will: - Not qualify for #Medicaid #rebates - Not affect best price - Not have an AMP or NADAC Bottom line: Importation likely saves nothing vs. Medicaid & #340B net prices! ==> drugch.nl/3j4JCf5
2
6
2
12
Size matters: @MedImpact 2019 #drug trend worse than big #PBMs (@CVSHealth $CVS & @ExpressScripts $CI) drugch.nl/31nQPjG Trad'l trend higher. Specialty trend only lower due to utilization (fewer Rx), not cost Similar to subscale @Prime_PBM (per drugch.nl/3fxt2lV)
3
4
9
FYI: @ahahospitals expresses "profound concern" over manufacturer actions re: #340B #contract #pharmacies drugch.nl/2Ypt2Oz Letter to @SecAzar @HHSGov: drugch.nl/32fvGaF Note: AHA doesn't (and can't) allege actions are "illegal" b/c it's all subregulatory!
2
4
5
Jeremy Docken retweeted
The gross to net bubble continues to increase as list prices for medications go higher and higher. The middlemen ARE NOT saving money for American patients. @TPPF @RightOnHC #txlege @DrugChannels @realDonaldTrump @Yost4Ohio @kenpax @Free2CareHC @Cotton_MT
2
16
4
33
Jeremy Docken retweeted
This! 🙌🏾 IG: kimberlylatricejones & djonesmedia
2,386
39,152
10,562
87,521
Jeremy Docken retweeted
This week's cover by American artist Titus Kaphar, who literally cut out the canvas to show a mother's loss. Read Kaphar's powerfully written work we published with the cover. shorturl.at/jsTW4 and @aaltman82 cover story ti.me/2AI37sj
2
23
57
Jeremy Docken retweeted
Say their names.
11
165
13
649